Journals / Türk Nöroşirürji Dergsi / 2017 / Cilt: 27 - Sayı: 2

Molecular Biology of Meningiomas

Meningiomların Moleküler Biyolojisi

Pages
169–175
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Molecular biological findings provide important clues on clinical behaviour of meningiomas.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Meningiomas are the most common type of brain tumor.
📊
Key Findings & Data:Although the current treatment of meningiomas is effective in most of the patients, several clinidal problems persist.
💡
Conclusion & Impact:Molecular biological findings provide important clues on clinical behaviour of meningiomas.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Meningiomas are the most common type of brain tumor. Although the current treatment of meningiomas is effective in most of the patients, several clinidal problems persist. To solve these problems a more thorough understanding of the meningioma biology is required. This review summarizes the current advances in meningioma biology. Molecular biological findings of classical and modern molecular techniques will be mentioned. Currently known molecular subsets will be correlated with clinical behavior. Findins on malignant degeneration and epigenetic findings will also be summarized. Meningiomas are genetically heterogenous tumors. Several molecular subsets exist, which differ in anatomical location, pathological subtype, clinical behavior, recurrence and malignant degeneration risk. Molecular biological findings provide important clues on clinical behaviour of meningiomas.

Özet

Meningiomlar en sık görülen beyin tümörlerinden birisidir. Her ne kadar meningiomların büyük bir çoğunluğu efektif şekilde tedavi edilebiliyor olsa da meningiomların tedavisinde hâlâ tedavi için ciddi sorunlar çıkarabilen problemler vardır. Bu problemlerin çözülebilmesi için meningiom biyolojisinin anlaşılması şarttır. Yazıda meningiom biyolojisi konusundaki gelişmeler özetlenecektir.Klasik ve modern moleküler yöntemlerle elde edilen bulgular anlatılacak, bu bulguların klinik fenotiple ilişkisi ortaya konulacak ve ardından meningiomlarda malign dejenerasyon konusundaki bulgular ve son olarak epigenetik değişiklikler ele alınacaktır. Meningiomlar genetik olarak heterojen bir gruptur. Farklı moleküler alt grupların yerleşim yeri, patolojik alt grup, klinik davranış, rekürrens ihtimali ve malign dejenerasyon riski açısından farklılıklar vardır. Moleküler biyolojik bulgular meningiomların klinik davranışı açısından önemli göstergelerdir.

🔖

Cite This Article

ÖZDUMAN, K., GÜDÜK, M., PAMİR, M. N. (2022). Molecular Biology of Meningiomas. Türk Nöroşirürji Dergsi, Cilt: 27 - Sayı: 2, 169–175. https://ajindex.com/articles/637435

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Abedalthagafi MS, Merrill PH, Bi WL, Jones RT, Listewnik ML, Ramkissoon SH, Thorner AR, Dunn IF, Beroukhim R, Alexander BM, Brastianos PK, Francis JM, Folkerth RD, Ligon KL, Van Hummelen P, Ligon AH, Santagata S: Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. Oncotarget 5(21): 10596-10606, 2014 2. Abedalthagafi M, Bi WL, Aizer AA, Merrill PH, Brewster R, Agarwalla PK, Listewnik ML, Dias-Santagata D, Thorner AR, Van Hummelen P, Brastianos PK, Reardon DA, Wen PY, AlMefty O, Ramkissoon SH, Folkerth RD, Ligon KL, Ligon AH, Alexander BM, Dunn IF, Beroukhim R, Santagata S: Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma: Neuro Oncol 18(5): 649-655, 2016 3. Al-Mefty O, Kadri PAS, Pravdenkova S, Sawyer JR, Stangeby C, Husain M: Malignant progression in meningioma: Documentation of a series and analysis of cytogenetic findings. J Neurosurg 101(2): 210-218, 2004 4. Bacci C, Sestini R, Provenzano A, Paganini I, Mancini I, Porfirio B, Vivarelli R, Genuardi M, Papi L: Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics 11(1): 73-80, 2010 5. Baia GS, Stifani S, Kimura ET, McDermott MW, Pieper RO, Lal A: Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. Neoplasia 10(6): 604-612, 2008 6. Bleeker FE, Felicioni L, Buttitta F, Lamba S, Cardone L, Rodolfo M, Scarpa A, Leenstra S, Frattini M, Barbareschi M, Grammastro MD, Sciarrotta MG, Zanon C, Marchetti A, Bardelli A: AKT1(E17K) in human solid tumours. Oncogene 27(42): 5648-5650, 2008 7. Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G: Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159(2): 661-669, 2001 8. Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, Ligon KL, Palescandolo E, Van Hummelen P, Ducar MD, Raza A, Sunkavalli A, Macconaill LE, StemmerRachamimov AO, Louis DN, Hahn WC, Dunn IF, Beroukhim R: Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45(3): 285-289, 2013 9. Buccoliero AM, Gheri CF, Castiglione F, Ammannati F, Gallina P, Taddei A, Garbini F, Rossi Degl'Innocenti D, Arganini L, Di Lorenzo N, Mennonna P, Taddei GL: Merlin expression in secretory meningio